Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?

This article from The Motley Fool compares the Invesco Pharmaceuticals ETF (PJP) and the iShares Global Healthcare ETF (IXJ) as investment options for healthcare exposure in 2026. PJP offers a concentrated U.S. pharma portfolio (29 holdings) with a 0.57% expense ratio and a 0.90% dividend yield, while IXJ provides a diversified global approach (110 holdings) with a lower 0.40% expense ratio and a higher 1.50% yield. Despite IXJ's lower cost and broader diversification, PJP outperforms in most time frames (YTD, 3-year, 5-year) with smaller drawdowns, though IXJ leads over 10 years (8.5% vs. 7.5% annualized). The article concludes that PJP is the better choice for investors seeking healthcare exposure due to its superior recent performance and concentrated small-cap focus.